Incyte Corporation is a biopharmaceutical company headquartered in Wilmington, Delaware, focused on discovering, developing, and commercializing innovative therapies in oncology and other serious diseases. Established in 1991, Incyte's commercial portfolio includes products such as Jakafi, a treatment for myelofibrosis and polycythemia vera, and its pipeline features numerous promising candidates targeting various malignancies. The company's strategic commitment to advancing precision medicine positions it as a significant player in the biopharma landscape, with robust research efforts aimed at addressing unmet medical needs. Incyte is dedicated to improving patient outcomes through scientific innovation and collaboration in the healthcare ecosystem.
Click "Analyze" to generate stock analysis
INCY Price Trend and Signals
INCY Option Volumes & Open Interests (aggregated)
INCY Put Call Ratios and IV (aggregated)
INCY Financials
2025-10-27Somewhat Bullishprice_signal
Yearly high detected.
2025-10-24Somewhat Bullishprice_signal
Yearly high detected.
2025-10-23Somewhat Bullishprice_signal
Yearly high detected.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.